Seqens is a global partner in health, personal care and specialty ingredients, leveraging 3300 employees, 16 manufacturing sites and 9 R&D centers in 9 countries. As an integrated player across the entire value chain – from raw materials to active ingredients and from R&D to industrialization – Seqens offers a broad portfolio of active pharmaceutical ingredients, pharmaceutical intermediates and specialty ingredients, develops and industrializes the most complex molecules, and leverages its ability to innovate, develop and implement the best available technologies. Driven by a culture of excellence and a strong entrepreneurial spirit, the group shares values such as unity, agility, and reactivity. Seqens provides the highest level of service and quality to more than 1500 customers around the world while acting ethically in accordance with its strong CSR program.